Medicinal Products

Eribulin EVER Pharma 0,44 mg/ml otopina za injekciju

Name Eribulin EVER Pharma 0,44 mg/ml otopina za injekciju
Marketing Authorisation Number HR-H-870080195
Active Substance eribulinmesilat
Composition jedan ml otopine sadrži 0,44 mg eribulina u obliku eribulinmesilata jedna bočica od 2 ml sadrži 0,88 mg eribulina u obliku eribulinmesilata jedna bočica od 3 ml sadrži 1,32 mg eribulina u obliku eribulinmesilata
Pharmaceutical Form otopina za injekciju
Manufacturer oncomed manufacturing a.s., Brno-Rečkovice, Češka
Ever Pharma Jena GmbH, Jena, Njemačka
Marketing Authorisation Holder EVER Valinject GmbH, Oberburgau 3, Unterach am Attersee, Austrija
Marketing Authorisation Date 09.05.2024
MA Period of Validity 09.05.2029
Classification Number UP/I-530-09/22-01/296
Registration Number 381-12-01/70-24-08
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product subject to restricted medical prescription
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code L01XX41
Marketing status Never marketed
SmPC download
PL download
Public Assessment Report download

Packaging

Back